RECONSTRUCTIVE arterial surgery has now progressed to a time when the majority of patients with ischemic disease of the lower extremities, associated with either complete or partial large-vessel ...

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the commercial release of the Pounce™ XL ...

There is evidence that screening for AAAs during lower extremity arterial evaluation is cost-effective and an appropriate and valuable contribution to the examination protocol. [110] Screening for ...